Skip to content
AnalystLens

ECOLAB INC. Quarterly Report for Q2 Ended Jun 30, 2009

Filing Date
Filed August 7, 2009
Period End
June 30, 2009
Security
ECL
One revenue dollarkept$0.07
In the record · 2016–202610-K1110-Q328-K144

ECL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 144 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Sep ’16Sep ’16
  2. Leadership change8-K · Apr ’19Apr ’19
  3. Deal closed8-K · Dec ’21Dec ’21
  4. Leadership change8-K · Aug ’25Aug ’25

Summary

Summary of the 10-Q filed August 7, 2009. Cited figures are marked; the original filing is the authoritative source.

Ecolab Inc. reported its second-quarter and first-half financial results for the period ending June 30, 2009.

The company experienced a decline in net sales, down 8%a for both the quarter and the year-to-date period, primarily due to unfavorable foreign currency exchange rates. When measured at fixed currency rates, sales were relatively flat year-over-year for the quarter. Operating income and net income attributable to Ecolab also saw significant decreases, largely impacted by substantial restructuring charges initiated in the first quarter of 2009 aimed at streamlining operations and improving efficiency.

These restructuring efforts involved workforce reductions and facility consolidations, with anticipated annualized pretax savings of $70b-80 million. Despite the challenging global economic environment and increased product costs, Ecolab demonstrated resilience through strong new account gains and pricing strategies, particularly in its U.S. Kay and Healthcare businesses, and Canadian operations, which reported double-digit growth.

The company is actively managing its costs and optimizing its business structure to mitigate the effects of the recession and improve profitability. Ecolab's financial position remains solid, with a decrease in its debt-to-capitalization ratio and sufficient liquidity through operating cash flow and credit facilities.

Key Highlights

  1. Consolidated net sales decreased by 8% to $1.4 billion for the second quarter and $2.8 billion for the first six months of 2009, primarily due to unfavorable foreign currency impacts.
  2. Operating income for the second quarter declined by 22% to $165 million, and for the first six months by 29% to $262.5 million, significantly impacted by restructuring charges.
  3. Net income attributable to Ecolab decreased by 29% to $99.1 million for the second quarter and by 35% to $156.5 million for the first six months of 2009.
  4. The company incurred significant restructuring charges of $24 million in Q2 2009 and $57 million year-to-date as part of a plan to reduce its global workforce and consolidate locations, expecting annualized pretax savings of $70-80 million.
  5. U.S. Cleaning & Sanitizing sales saw a modest increase of 1% in the second quarter, driven by strong performance in Kay and Healthcare segments, while International sales, at fixed currency rates, declined 1%.
  6. The debt-to-capitalization ratio improved to 37% at June 30, 2009, down from 42% at December 31, 2008, indicating a stronger balance sheet.
  7. Cash provided by operating activities was $299.4 million for the first six months of 2009, slightly down from $310.7 million in the prior year, impacted by a voluntary pension contribution and lower earnings.

Follow one dollar

Of each $1.00 of revenue in Q2 FY2009, Ecolab Inc. kept $0.07.

  1. Revenue$1.44B100.0%
  2. Cost of revenue−$725.1M50.3%
  3. Gross profit$716.4M49.7%
  4. Operating costs−$551.4M38.3%
  5. Operating income$165.0M11.4%
  6. Interest, other & tax−$65.5M4.5%
  7. Net income$99.5M6.9%
Computed from 10-QQ2 FY2009filed August 7, 2009Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q2 FY2009 against Q2 FY2008

Line itemQ2 FY2009Q2 FY2008Change
Revenue$1.44B$1.57B−8.2%
Cost of Revenue$725.10M$798.80M−9.2%
Gross Profit$716.40M$771.20M−7.1%
SG&A Expenses$526.40M$580.00M−9.2%
Operating Income$165.00M$210.50M−21.6%
Interest Expense$16.90M——
Net Income$99.50M$139.00M−28.4%
EPS (Basic)$0.42$0.56−25.0%
EPS (Diluted)$0.41$0.55−25.5%
Shares Outstanding (Basic)236.50M247.10M−4.3%
Shares Outstanding (Diluted)239.50M251.40M−4.7%

Frequently Asked Questions

  1. What were the primary drivers of the sales decline in the second quarter of 2009?

    The primary driver for the 8% decline in consolidated net sales during the second quarter of 2009 was unfavorable foreign currency exchange rates. Excluding this impact, net sales were flat compared to the prior year, indicating resilience in underlying business performance despite the global recession.

  2. What is the impact of the restructuring charges on Ecolab's financial results?

    The company recorded significant restructuring charges totaling $24 million in the second quarter and $57 million for the first six months of 2009. These charges negatively impacted reported operating income, net income, and earnings per share. However, these actions are expected to generate substantial annualized pretax savings of $70-80 million, which should benefit future profitability.

  3. How is Ecolab managing its financial condition and liquidity amidst economic uncertainty?

    Ecolab is actively managing its financial position by reducing debt, as evidenced by the improved debt-to-capitalization ratio. The company maintains sufficient liquidity through strong operating cash flow and access to credit facilities, including a $600 million multi-year credit facility. They expect to fund foreseeable cash requirements through operating activities, cash reserves, and borrowings.

  4. Which segments or regions performed well despite the overall challenging economic conditions?

    The U.S. Kay and Healthcare businesses showed strong double-digit growth in the second quarter. Internationally, Canada and Latin America experienced robust sales growth of 10% and 8% respectively (at fixed currency rates), demonstrating specific regional strengths.